Setareh Seyedkazemi's Insider Trades & SAST Disclosures
Setareh Seyedkazemi's most recent trade in Adverum Biotechnologies Inc was a trade of 924 Common Stock done at an average price of $2 . Disclosure was reported to the exchange on May 15, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Setareh Seyedkazemi.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Adverum Biotechnologies Inc | Setareh Seyedkazemi | CHIEF DEVELOPMENT OFFICER | Sale of securities on an exchange or to another person at price $ 2.00 per share. | 15 May 2025 | 924 | 13,768 (0%) | 0% | 2 | 1,848 | Common Stock |
| Adverum Biotechnologies Inc | Setareh Seyedkazemi | CHIEF DEVELOPMENT OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 48,750 | 48,750 | - | - | Stock Option (Right to Buy) | |
| Adverum Biotechnologies Inc | Setareh Seyedkazemi | CHIEF DEVELOPMENT OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 8,125 | 14,692 (0%) | 0% | 0 | Common Stock | |
| Adverum Biotechnologies Inc | Setareh Seyedkazemi | CHIEF DEVELOPMENT OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2024 | 43,458 | 43,458 | - | - | Stock Option (Right to Buy) | |
| Adverum Biotechnologies Inc | Setareh Seyedkazemi | CHIEF DEVELOPMENT OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 400,000 | 400,000 | - | - | Stock Option (Right to Buy) | |
| Adverum Biotechnologies Inc | Setareh Seyedkazemi | CHIEF DEVELOPMENT OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2023 | 85,000 | 85,000 | - | - | Stock Option (Right to Buy) | |
| Adverum Biotechnologies Inc | Setareh Seyedkazemi | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 1.52 per share. | 15 Sep 2023 | 6,071 | 47,804 (0%) | 0% | 1.5 | 9,228 | Common Stock |
| Adverum Biotechnologies Inc | Setareh Seyedkazemi | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 1.55 per share. | 15 Sep 2023 | 130 | 47,674 (0%) | 0% | 1.5 | 201 | Common Stock |
| Adverum Biotechnologies Inc | Setareh Seyedkazemi | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 250,000 | 250,000 | - | - | Stock Option (Right to Buy) | |
| Adverum Biotechnologies Inc | Setareh Seyedkazemi | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 1.07 per share. | 19 Sep 2022 | 6,058 | 47,875 (0%) | 0% | 1.1 | 6,480 | Common Stock |
| Adverum Biotechnologies Inc | Setareh Seyedkazemi | Chief Development Officer | Purchase of securities on an exchange or from another person at price $ 0.84 per share. | 23 May 2022 | 20,000 | 20,600 (0%) | 0% | 0.8 | 16,800 | Common Stock |
| Adverum Biotechnologies Inc | Setareh Seyedkazemi | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2022 | 425,000 | 425,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges